United States · Venture startup

Who invested in Pharmacopeia

One round we have observed, with the 10 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$7.6Mraised across 1 round since 2005, from 1 source

Latest round
Venture, $7.6MJul 2005
Investors
10
See who backed them

The rounds

  1. Jul 2005
    Venture$7.6M

    From a historical funding record

The exit

ExitBuyerPriceWhen
AcquiredLigand Pharmaceuticals$73MSept 2008

From historical deal records. Wrong? Tell us.

Everyone who backed them

Iroquois CapitalHedge fund1round
Downsview CapitalVC firm1round
Balyasny Asset Management L.p.Private equity1round
Clarion Capital PartnersPrivate equity1round
Crestview CapitalVC firm1round
Carpe Diem Capital Managementno record of our own yet1round
Fifth Third Asset Managementno record of our own yet1round
Rima Managementno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Pharmacopeia

Who invested in Pharmacopeia?

Pharmacopeia's investors include Iroquois Capital, Downsview Capital, Balyasny Asset Management L.p., Highbridge Capital Management and Nite Capital Management, and 5 more on record.

How much has Pharmacopeia raised?

Pharmacopeia has raised $7.6M across 1 round since 2005.

When did Pharmacopeia last raise?

Pharmacopeia's most recent round was a Venture of $7.6M in Jul 2005.

What was Pharmacopeia's biggest round?

Its most recent round, $7.6M in Jul 2005, is also its largest on record.

Who backed Pharmacopeia first?

Pharmacopeia's first round on record, in Jul 2005, was backed by Iroquois Capital, Downsview Capital and Balyasny Asset Management L.p. and 7 others.

What stage is Pharmacopeia at?

Pharmacopeia's latest named round is a Venture, in Jul 2005.

Where is Pharmacopeia based?

Pharmacopeia is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.